Novo Nordisk Owner to Open Obesity Drug Incubators Across Europe (opens in new tab)

The primary owner of Ozempic maker Novo Nordisk A/S is launching a network of research incubators across Europe, seeking to create breakthrough obesity and diabetes treatments by turning academic discoveries into commercial ventures.